Overview
Akira Matsushima practices practicing medicine in Shinshu, Japan.
Matsushima is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Spinocerebellar Ataxia Type 31, Cerebellar Multiple System Atrophy, Spinocerebellar Ataxia Type 6, and Drug Induced Dyskinesia.
They are actively involved in clinical research, co-authoring 25 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Akira Matsushima
Is Akira Matsushima a top-rated expert for Spinocerebellar Ataxia Type 31?
MediFind is an objective health platform that identifies experts based on real-world data. Akira Matsushima is classified as an Distinguished expert for Spinocerebellar Ataxia Type 31, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Akira Matsushima participate in research or clinical trials?
Yes. Akira Matsushima has published 25 articles and abstracts on conditions like Spinocerebellar Ataxia Type 31. You can view a list of Akira Matsushima's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Spinocerebellar Ataxia Type 31Matsushima isDistinguished. Learn about Spinocerebellar Ataxia Type 31.
- Advanced
- Cerebellar Multiple System Atrophy
- Spinocerebellar Ataxia Type 6Matsushima isAdvanced. Learn about Spinocerebellar Ataxia Type 6.
- Experienced
- Acute Cerebellar AtaxiaMatsushima isExperienced. Learn about Acute Cerebellar Ataxia.
- Alternating Hemiplegia of ChildhoodMatsushima isExperienced. Learn about Alternating Hemiplegia of Childhood.
- CACH SyndromeMatsushima isExperienced. Learn about CACH Syndrome.
- Cardiac AmyloidosisMatsushima isExperienced. Learn about Cardiac Amyloidosis.
- Cerebral Amyloid AngiopathyMatsushima isExperienced. Learn about Cerebral Amyloid Angiopathy.
- Drug Induced DyskinesiaMatsushima isExperienced. Learn about Drug Induced Dyskinesia.
- Familial DysautonomiaMatsushima isExperienced. Learn about Familial Dysautonomia.
- Familial Transthyretin AmyloidosisMatsushima isExperienced. Learn about Familial Transthyretin Amyloidosis.
- HemiplegiaMatsushima isExperienced. Learn about Hemiplegia.
- Hereditary AtaxiaMatsushima isExperienced. Learn about Hereditary Ataxia.
- Movement DisordersMatsushima isExperienced. Learn about Movement Disorders.
- Multiple System AtrophyMatsushima isExperienced. Learn about Multiple System Atrophy.
- Olivopontocerebellar AtrophyMatsushima isExperienced. Learn about Olivopontocerebellar Atrophy.
- Primary AmyloidosisMatsushima isExperienced. Learn about Primary Amyloidosis.
- Progressive Multifocal Leukoencephalopathy
- Spinocerebellar AtaxiaMatsushima isExperienced. Learn about Spinocerebellar Ataxia.
- Spinocerebellar Ataxia Type 4Matsushima isExperienced. Learn about Spinocerebellar Ataxia Type 4.
- Spinocerebellar Ataxia Type 5Matsushima isExperienced. Learn about Spinocerebellar Ataxia Type 5.
- Transthyretin AmyloidosisMatsushima isExperienced. Learn about Transthyretin Amyloidosis.